Načítá se...
Novel and combination therapies for polycythemia vera and essential thrombocythemia: the dawn of a new era
INTRODUCTION: Essential thrombocythemia (ET) and polycythemia vera (PV) belong to the BCR-ABL1-negative myeloproliferative neoplasms and are characterized by the clonal proliferation of hematopoietic stem and progenitor cells. The contribution of aberrant immune regulation within the bone marrow mic...
Uloženo v:
| Vydáno v: | Expert Rev Hematol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7722191/ https://ncbi.nlm.nih.gov/pubmed/33076714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2020.1839887 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|